首页> 外文期刊>The Lancet >The restless legs syndrome
【24h】

The restless legs syndrome

机译:不安腿综合症

获取原文
获取原文并翻译 | 示例
           

摘要

The restless legs syndrome is a common disorder that encompasses an idiopathic form of genetic or unknown origin and symptomatic forms associated with many causes. Symptomatic forms occur during pregnancy and are coincident with uraemia, iron depletion, polyneuropathy, spinal disorders, and rheumatoid arthritis. For the hereditary forms, at least three gene loci, located on chromosomes 12,14, and 9, have been traced so far. Prevalence in the general population is between 3% and 9%, increases with age, and is higher in women than in men. Treatment is needed only in the moderate to severe forms of the disorder and mostly in elderly people. Pathophysiology and treatment may be closely linked to the dopaminergic system and iron metabolism. Dopaminergic treatment with levodopa and dopamine agonists is the first choice in idiopathic restless legs syndrome, but augmentation and rebound should be monitored in long-term treatment. Various other drugs, such as opioids, gabapentin, and benzodiazepines, provide alternative treatment possibilities.
机译:不安腿综合症是一种常见的疾病,包括遗传性或未知来源的特发性形式以及与许多原因相关的症状形式。有症状的形式在怀孕期间发生,并与尿毒症,铁耗竭,多发性神经病,脊柱疾病和类风湿性关节炎同时发生。对于遗传形式,到目前为止已经追踪了位于染色体12、14和9上的至少三个基因位点。普通人群的患病率在3%至9%之间,随着年龄的增长而增加,女性的患病率高于男性。仅在中度至重度的疾病中需要治疗,而在老年人中则需要治疗。病理生理学和治疗可能与多巴胺能系统和铁代谢密切相关。左旋多巴和多巴胺激动剂对多巴胺能的治疗是特发性躁动腿综合征的首选,但长期治疗应监测其增加和反弹。各种其他药物,例如阿片类药物,加巴喷丁和苯二氮卓类药物,提供了替代治疗的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号